Skip to main content
Clinical Trials/NCT06219837
NCT06219837
Recruiting
Not Applicable

Subarachnoid Block Versus Ultrasound Guided Transversalis Fascia Plane Block for Postoperative Analgesia of Inguinal Hernia Repair in Adults: A Randomized, Double Blinded, Controlled Trial

Cairo University1 site in 1 country80 target enrollmentAugust 1, 2023

Overview

Phase
Not Applicable
Intervention
bupivacaine injection by ultrasound guided transversalis fascia plane block
Conditions
Postoperative Analgesia of Inguinal Hernia Repair in Adults
Sponsor
Cairo University
Enrollment
80
Locations
1
Primary Endpoint
The total amount of postoperative morphine consumption during the first 24hrs postoperative.
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

The aim of our study is to investigate the effect of the ultrasound guided transversalis fascia plane block on the postoperative opioid consumption as a part of multimodal analgesia in patients undergoing inguinal herniorrhaphy under spinal anesthesia.

Detailed Description

The aim of our study is to investigate the efficacy of the ultrasound-guided transversalis fascia plane block as a postoperative analgesia as a part of multimodal analgesia in patients undergoing inguinal herniorrhaphy under spinal anesthesia. The ultrasound (US)-guided transversalis fascia plane (TFP) block was first described by Hebbard in 2009. A local anesthetic (LA) injected between the transversus abdominis muscle, and its deep investing fascia will block the anterior and the lateral branches of the T12 and L1 nerves (4). The efficacy of this block has been demonstrated in iliac crest bone graft harvesting, caesarean section and inguinal herniorrhaphy

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
October 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Rabab

lecture of anathesia

Cairo University

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing inguinal herniorrhaphy.
  • Patients 18-60 years.
  • ASA I and II.
  • Both sexes.
  • Having no contraindication for spinal anesthesia or TFP block.

Exclusion Criteria

  • Refusal of regional anesthesia.
  • Infection in the back or at the site of injection for TFP block.
  • INR \> 1.
  • Platelet count \< 80000 per microliter of blood.
  • Patients known to be allergic to amide local anesthetics.
  • BMI greater than 35 kgm_
  • Opioid addiction.
  • Have communication problems that may hinder the assessement of pain postoperative.

Arms & Interventions

bupivacaine group

the patient in this arm will receive 20 ml of 0.25% bupivacaine injection by ultrasound guided transversalis fascia block for inguinal herniorraphy

Intervention: bupivacaine injection by ultrasound guided transversalis fascia plane block

20 ml of 0.9% normal saline solution

he patient in this arm will receive 20 ml of 0.9% normal saline solution by ultrasound guided transversalis fascia block for inguinal herniorraphy

Intervention: bupivacaine injection by ultrasound guided transversalis fascia plane block

Outcomes

Primary Outcomes

The total amount of postoperative morphine consumption during the first 24hrs postoperative.

Time Frame: First 24 hours postoperative

The patients will be evaluated regarding the first demand to rescue analgesia postoperatively. The pain will be assessed by the VAS score. It will be performed in the immediate post-operative period every 15 min for the first 60 min, 2 h, 4 h, 8h, 12h, 18 and 24 h. Breakthrough pain will be defined as VAS \>4 at rest.

Study Sites (1)

Loading locations...

Similar Trials